WallStreetZenWallStreetZen

NASDAQ: RLAY
Relay Therapeutics Inc Stock Ownership - Who owns Relay Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Relay Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter RahmerChief Corporate Development Officer Exhibit 24 - Power of Attorney2025-10-2921,394$7.50
$160.46kSell
Donald A. BergstromPresident RD2025-10-2830,897$7.29
$225.24kSell
Peter RahmerChief Corporate Development Officer Exhibit 24 - Power of Attorney2025-10-2819,135$7.29
$139.49kSell
Thomas CatinazzoChief Financial Officer2025-10-2821,664$7.29
$157.93kSell
Thomas CatinazzoChief Financial Officer2025-07-2918,380$3.68
$67.64kSell
Donald A. BergstromPresident RD2025-07-2926,701$3.68
$98.26kSell
Brian AdamsChief Legal Officer2025-07-2918,276$3.68
$67.26kSell
Peter RahmerChief Corporate Develpment Officer2025-07-2915,724$3.68
$57.86kSell
Thomas CatinazzoChief Financial Officer2025-07-281,701$3.74
$6.36kSell
Peter RahmerChief Corporate Develpment Officer2025-07-281,359$3.74
$5.08kSell

1 of 6

RLAY insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLAY insiders and whales buy or sell their stock.

RLAY Shareholders

What type of owners hold Relay Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Svf Pauling Cayman Ltd16.28%27,904,963$199.24MInsider
Sb Investment Advisers Uk Ltd16.28%27,904,963$199.24MInstitution
Blackrock Inc8.14%13,954,486$99.64MInstitution
Point72 Asset Management LP7.84%13,445,704$96.00MInstitution
Commodore Capital LP7.79%13,350,000$95.32MInstitution
Casdin Capital LLC6.65%11,398,574$81.39MInstitution
Third Rock Ventures III LP6.15%10,551,115$75.33MInsider
Vanguard Group Inc5.47%9,379,851$66.97MInstitution
Bellevue Group Ag4.80%8,230,870$58.77MInstitution
Tang Capital Management LLC4.71%8,068,058$57.61MInstitution

1 of 3

RLAY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLAY78.09%21.91%Net SellingNet Selling
PHVS82.28%0.00%
PGEN22.39%77.61%Net SellingNet Selling
IMTX76.59%0.00%
AMLX59.67%40.33%Net SellingNet Selling
View Top Biotech Stocks

Relay Therapeutics Stock Ownership FAQ

Who owns Relay Therapeutics?

Relay Therapeutics (NASDAQ: RLAY) is owned by 99.73% institutional shareholders, 27.99% Relay Therapeutics insiders, and 0.00% retail investors. Svf Pauling Cayman Ltd is the largest individual Relay Therapeutics shareholder, owning 27.90M shares representing 16.28% of the company. Svf Pauling Cayman Ltd's Relay Therapeutics shares are currently valued at $199.24M.

If you're new to stock investing, here's how to buy Relay Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.